We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

54 hedge funds and large institutions have $31.4M invested in Applied Genetic Technologies Corporation in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $30M → $31.4M (+$1.38M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

13% less funds holding

Funds holding: 6254 (-8)

38% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 21

54% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 13

Holders
54
Holders Change
-8
Holders Change %
-12.9%
% of All Funds
1.24%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
13
Reduced
21
Closed
13
Calls
$86K
Puts
Net Calls
+$86K
Net Calls Change
+$86K

AGTC Hedge Fund Activity: Q1 2018 in Review

54 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q1 2018, worth a combined $31.4M — up 4.6% from $30M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of AGTC and 6 opened new positions — a net loss of 7 holders — while 21 trimmed existing stakes and 13 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $757K. The largest seller was Fidelity Investments, cutting an estimated $456K.

  • 54 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q1 2018, down from 62 in Q4 2017.
  • Funds reported $31.4M of Applied Genetic Technologies Corporation stock for Q1 2018, up 4.6% quarter-over-quarter.
  • 6 funds opened new Applied Genetic Technologies Corporation positions in Q1 2018 and 13 closed out, a net change of -7 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q1 2018 was Point72 Asset Management, an estimated $757K added.
  • The largest Applied Genetic Technologies Corporation seller in Q1 2018 was Fidelity Investments, an estimated $456K sold.

Based on aggregated 13F filings for Q1 2018.